ViewRay® to Present at the Morgan Stanley 20th Annual Global Healthcare Conference

Rhea-AI Summary

ViewRay, Inc. (NASDAQ: VRAY) will present at the Morgan Stanley 20th Annual Global Healthcare Conference on September 13, 2022, at 8:00 a.m. ET. Scott Drake, President and CEO, and Zach Stassen, CFO, will participate in a fireside chat during this event. An audio webcast will be accessible on the investor relations section of ViewRay's website and will be available for replay for 7 days post-presentation.

ViewRay specializes in designing and marketing the MRIdian MRI-Guided Radiation Therapy System, tailored to enhance advanced radiation oncology.

News Market Reaction – VRAY

-0.28%

-0.28% Session move

In the trading session that priced this news, VRAY declined 0.28%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

DENVER, Sept. 9, 2022 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) announced today that the Company will present at the Morgan Stanley 20^th Annual Global Healthcare Conference. Scott Drake, President and Chief Executive Officer, and Zach Stassen, Chief Financial Officer, will participate in a fireside chat at 8:00 a.m. Eastern Time on Tuesday, September 13, 2022.

An audio webcast of the Company's presentation will be available on the investor relations section of ViewRay's website at http://investors.viewray.com/events-and-presentations/upcoming-events. A replay of the webcast will be available for 7 days after the date of the presentation.

About ViewRay

ViewRay, Inc. (Nasdaq: VRAY), designs, manufactures, and markets the MRIdian^® MRI-Guided Radiation Therapy System. MRIdian is built upon a proprietary high-definition MR imaging system designed from the ground up to address the unique challenges and clinical workflow for advanced radiation oncology. Unlike MR systems used in diagnostic radiology, MRIdian's high-definition MR was purpose-built to address specific challenges, including beam distortion, skin toxicity, and other concerns that potentially may arise when high magnetic fields interact with radiation beams. ViewRay and MRIdian are registered trademarks of ViewRay, Inc.

View original content:https://www.prnewswire.com/news-releases/viewray-to-present-at-the-morgan-stanley-20th-annual-global-healthcare-conference-301621041.html

SOURCE ViewRay, Inc.

FAQ

What time will ViewRay present at the Morgan Stanley conference on September 13, 2022?

ViewRay will present at 8:00 a.m. Eastern Time.

Who will represent ViewRay at the Morgan Stanley 20th Annual Global Healthcare Conference?

Scott Drake, President and CEO, and Zach Stassen, CFO, will represent ViewRay.

Where can I find the audio webcast of ViewRay's presentation?

The audio webcast will be available on the investor relations section of ViewRay's website.

How long will the audio webcast of ViewRay's presentation be available for replay?

The replay of the webcast will be available for 7 days after the presentation.

What does ViewRay's MRIdian system focus on?

The MRIdian system is designed for advanced radiation oncology, addressing challenges like beam distortion and skin toxicity.